A bill to reduce the price of insulin and provide for patient protections with respect to the cost of insulin.

This bill, designated as S. 4189 in the 119th Congress, was introduced on March 25, 2026. Its purpose is to lower the cost of insulin and establish safeguards for patients regarding the expenses associated with insulin.